Source: iQoncept / Shutterstock
Alaunos Therapeutics (NASDAQ:TCRT) just reported results for the first quarter of 2024.
- Alaunos Therapeutics reported earnings per share of -11 cents.
- The company reported revenue of $1,000.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/tcrt-stock-earnings-alaunos-therapeutics-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC